The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone
Figure 1
A total of 126 patients who were clinically diagnosed NAFLD with type 2 DM visited the outpatient clinic of Department of Diabetes and Metabolism or Department of Gastroenterology, Mitsui Memorial Hospital. We retrospectively analyzed 82 of them, excluding 44 patients only treated with insulin injection or exercise and diet therapy. We divided the rest 82 patients into three groups: liraglutide-treated group (), sitagliptin-treated group (), and pioglitazone-treated group ().
